Some regional pathologic and metabolic consequences in mouse brain of pyrithiamine-induced thiamine deficiency.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001479:Basal Ganglia / Q000473:pathology; D001921:Brain / Q000378:metabolism / Q000473:pathology*; D002531:Cerebellum / Q000378:metabolism; D002908:Chronic Disease; D003401:Creatine / Q000378:metabolism; D003593:Cytoplasm; D005942:Gluconates / Q000378:metabolism; D006624:Hippocampus / Q000473:pathology; D006651:Histocytochemistry; D007656:Ketoglutaric Acids / Q000378:metabolism; D051379:Mice; D009474:Neurons; D011726:Pyridinium Compounds / Q000008:administration & dosage; D003336:Tectum Mesencephali / Q000473:pathology; D013788:Thalamus / Q000378:metabolism / Q000473:pathology; D013832:Thiamine Deficiency / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology*; D014726:Vestibular Nuclei / Q000473:pathology
D005942:Gluconates; D007656:Ketoglutaric Acids; D011726:Pyridinium Compounds; D000255:Adenosine Triphosphate; D003401:Creatine